https://doctransparency.com/doctor/fl/st-petersburg/david-eichenbaum-1144251356
Medicare Enrolled

Dr. David Eichenbaum, M.D.

Retina Specialist (Ophthalmology) Physician · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
4344 CENTRAL AVE, St Petersburg, FL 33711
7273230077
In practice since 2006 (19 years)
NPI: 1144251356 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Eichenbaum from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Eichenbaum? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Eichenbaum

Dr. David Eichenbaum is a retina specialist (ophthalmology) physician in St Petersburg, FL, with 19 years in practice. Based on federal Medicare data, Dr. Eichenbaum performed 47,756 Medicare services across 3,685 unique beneficiaries.

Between the years covered by Open Payments, Dr. Eichenbaum received a total of $1,688,189 from 53 pharmaceutical and/or device companies across 1773 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Eichenbaum is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 8% volume in FL$ $1,688,189 industry payments

Medicare Practice Summary

Medicare Utilization ↗
47,756
Medicare services
Top 8% in FL for retina specialist (ophthalmology) physician
3,685
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,513 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)37,080$29$100
Retinal imaging (OCT scan)1,940$28$65
Aflibercept eye injection (Eylea)1,660$690$2,000
Eye injection for retinal disease1,650$94$642
Injection, ranibizumab, 0.1 mg1,553$181$985
Comprehensive eye exam, established patient949$87$200
Injection, pegcetacoplan, intravitreal, 1 mg810$117$387
Retinal photography (fundus photo)476$26$100
Eye exam, established patient, focused382$65$150
Extended exam of the back part of the eye with optic nerve drawing373$11$40
Injection, dexamethasone, intravitreal implant, 0.1 mg294$158$430
Comprehensive eye exam, new patient183$100$220
Compounded drug, not otherwise classified105$63$500
Extended exam of the back part of the eye with retinal drawing89$17$50
Unclassified drugs57$1,814$6,000
Exam of retinal blood vessels using a special camera after injection of a dye46$106$200
Unclassified biologics46$1,868$6,000
Exam of the internal drainage system of eye28$19$70
2d ultrasound scan of eye tissue and structures21$37$150
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye14$200$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,688,189
Total received (2018-2024)
Avg $241,170/year across 7 years
Top 0% in FL for retina specialist (ophthalmology) physician
53
Companies
1,773
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$915,127 (54.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$744,278 (44.1%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$21,162 (1.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,622 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$286,227
2023
$198,703
2022
$272,409
2021
$198,330
2020
$150,752
2019
$328,545
2018
$253,224

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$364,419
Novartis Pharmaceuticals Corporation
$174,198
Allergan Inc.
$161,873
Apellis Pharmaceuticals, Inc.
$154,042
Regeneron Healthcare Solutions, Inc.
$118,554
Genentech, Inc.
$94,618
Allergan, Inc.
$79,815
EyePoint Pharmaceuticals US, Inc.
$71,542
ABBVIE INC.
$71,468
F. Hoffmann-La Roche AG
$71,252
Astellas Pharma US Inc
$66,171
Ocular Therapeutix, Inc.
$45,634
Alimera Sciences, Inc.
$24,960
Regeneron Pharmaceuticals, Inc.
$24,821
Bausch & Lomb, a division of Bausch Health US, LLC
$24,404
Dutch Ophthalmic, USA
$23,564
Bausch & Lomb Americas Inc.
$21,231
US Retina LLC
$21,162
NotalVision
$16,323
Celgene Corporation
$14,570
Novartis Pharma AG
$11,275
Roche Products Limited
$8,863
ThromboGenics, Inc.
$5,296
PFIZER INC.
$3,710
Hoffmann-La Roche Limited
$3,343
Harrow Eye, LLC
$2,452
Coherus Biosciences Inc.
$1,525
Oculus Surgical Inc.
$1,194
Boehringer Ingelheim International GmbH
$950
Roche TCRC, Inc.
$842
E.R. Squibb & Sons, L.L.C.
$788
Alcon Vision LLC
$738
Mallinckrodt Hospital Products Inc.
$642
NATUS MEDICAL INCORPORATED
$337
Horizon Therapeutics plc
$238
Sandoz Inc.
$214
Biogen, Inc.
$149
Glaukos Corporation
$130
Kala Pharmaceuticals, Inc.
$125
Dompe US, Inc.
$122
Spark Therapeutics, Inc.
$120
Ivantis, Inc
$117
SANOFI-AVENTIS U.S. LLC
$99
Carl Zeiss Meditec, Inc.
$70
Celltrion USA Inc.
$41
Astellas Pharma Global Development
$36
Alcon Research LLC
$36
ANI Pharmaceuticals, Inc.
$28
Sun Pharmaceutical Industries Inc.
$22
Amgen Inc.
$19
Carl Zeiss Meditec AG
$19
Rhythm Pharmaceuticals, Inc.
$16
Vyera Pharmaceuticals, LLC
$14
Top 3 companies account for 41.5% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · BEOVU · BROLUCIZUMAB · BromSite (bromfenac ophthalmic solution) 0.075% · COMBIGAN · CRYSTALENS · Cimerli · Constellation · DEXTENZA · DEXYCU · Daraprim Tablet 25mg · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYP-1901 · EYSUVIS · Empaveli · ForeseeHome · Hydrus · IHEEZO · ILUVIEN · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · Iluvien · Izervay · Jetrea · LOTEMAX SM · LUXTURNA · Lucentis · NGENUITY · Non-Covered Product · None Specified · OXERVATE · OZURDEX · Ozanimod · PROLENSA · PURIFIED CORTROPHIN GEL · RETISERT · ReSure Sealant · STELLARIS · SUSVIMO · Susvimo · Syfovre · TEPEZZA · TZIELD · VABYSMO · VEGZELMA · VELSIPITY · VISUDYNE · VYZULTA · Vabysmo · XEN · XIIDRA · XIPERE · YUTIQ · ZEPOSIA · combined machine · iDose
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for retina specialist (ophthalmology) physician in FL.

Equivalent to $3,535 per 100 Medicare services performed
Looking for a retina specialist (ophthalmology) physician in St Petersburg?
Compare retina specialist (ophthalmology) physicians in the St Petersburg area by procedure volume, costs, and industry payment transparency.
Browse retina specialist (ophthalmology) physicians nearby

Geographic Context

Retina Specialist (Ophthalmology) Physicians within 10 mi
14
Per 100K population
1.5
County median income
$70,293
Nearest hospital
HCA FLORIDA PASADENA HOSPITAL A PART OF HCA FLORID
2.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Eichenbaum is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Eichenbaum experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Eichenbaum performed 37,080 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Eichenbaum receive payments from pharmaceutical companies?
Yes. Dr. Eichenbaum received a total of $1,688,189 from 53 companies across 1,773 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Eichenbaum's costs compare to other retina specialist (ophthalmology) physicians in St Petersburg?
Dr. Eichenbaum's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Eichenbaum) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →